Liquidia Co. (NASDAQ:LQDA) Sees Large Decline in Short Interest

Liquidia Co. (NASDAQ:LQDA) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 3,170,000 shares, a decrease of 8.4% from the October 15th total of 3,460,000 shares. Based on an average daily volume of 425,800 shares, the short-interest ratio is currently 7.4 days.

Wall Street Analyst Weigh In

LQDA has been the topic of a number of recent analyst reports. Wedbush reissued an “outperform” rating and issued a $3.00 price objective on shares of Liquidia in a research note on Thursday, November 9th. HC Wainwright reiterated a “buy” rating and issued a $16.00 target price on shares of Liquidia in a report on Friday, August 11th. Finally, Needham & Company LLC reissued a “buy” rating and set a $18.00 target price on shares of Liquidia in a research report on Wednesday, November 8th.

Institutional Investors Weigh In On Liquidia

A number of institutional investors have recently added to or reduced their stakes in the company. BNP Paribas Arbitrage SNC grew its position in Liquidia by 20.5% in the first quarter. BNP Paribas Arbitrage SNC now owns 9,993 shares of the company’s stock valued at $69,000 after acquiring an additional 1,702 shares during the period. Chartwell Investment Partners LLC boosted its position in Liquidia by 6.0% in the fourth quarter. Chartwell Investment Partners LLC now owns 31,024 shares of the company’s stock valued at $197,000 after buying an additional 1,769 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Liquidia by 7.1% during the fourth quarter. JPMorgan Chase & Co. now owns 27,923 shares of the company’s stock worth $178,000 after buying an additional 1,845 shares during the last quarter. Corton Capital Inc. increased its holdings in shares of Liquidia by 14.2% during the third quarter. Corton Capital Inc. now owns 23,440 shares of the company’s stock worth $149,000 after buying an additional 2,921 shares in the last quarter. Finally, BlackRock Inc. increased its holdings in Liquidia by 0.4% during the 1st quarter. BlackRock Inc. now owns 846,385 shares of the company’s stock valued at $6,077,000 after purchasing an additional 3,042 shares in the last quarter. 45.03% of the stock is owned by institutional investors and hedge funds.

Liquidia Price Performance

NASDAQ:LQDA traded down $0.05 during trading hours on Friday, hitting $6.26. 241,066 shares of the company traded hands, compared to its average volume of 494,365. Liquidia has a twelve month low of $4.48 and a twelve month high of $9.95. The firm has a 50-day moving average of $6.42 and a 200 day moving average of $7.32.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension.